v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (11,855) $ (33,852)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 8,648 10,290
Amortization of deferred financing fees 842 322
Deferred income taxes 103  
Loss on impairment of assets 226 12,100
Changes in operating assets and liabilities:    
Receivables (8,290) 4,462
Inventories (10,421) 4,848
Other current assets (4,850) 2,344
Other assets (237) 11,363
Accounts payable (3,129) (5,434)
Accrued liabilities 1,772 (395)
Accrued employee benefits (338) (1,503)
Other 9 (2,171)
Total adjustments (15,665) 36,226
Net cash (used in) provided by operating activities (27,520) 2,373
Cash flows from investing activities:    
Capital expenditures (16,682) (16,342)
Net cash used in investing activities (16,682) (16,342)
Cash flows from financing activities:    
Cash acquired in connection with reverse recapitalization 40,855  
Deferred financing costs (1,958) (300)
Issuance of common stock 15,000 15,000
Repayment of short-term debt (11,547) (5,625)
Proceeds from long-term debt 647 7,758
Net cash provided by financing activities 42,997 16,833
Effect of currency exchange rate changes on cash (101) 344
Net increase in cash and equivalents (1,306) 3,208
Cash, equivalents and restricted cash at beginning of period 9,217 5,704
Cash, equivalents and restricted cash at end of period 7,911 8,912
Supplemental cash flow information:    
Interest paid less capitalized interest 4,684 5,274
Income taxes paid 2,512 $ 200
Capital Expenditure in Accounts Payable $ 2,699